Get App

Pfizer in talks with India over expedited approval for Covid-19 vaccine

Pfizer vaccine is not registered in India although an application was submitted months ago
  • Published On May 3, 2021 at 01:00 PM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its Covid-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.

"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," he said.

"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country."
  • Published On May 3, 2021 at 01:00 PM IST
Be the first one to comment.
Comment Now

COMMENTS

Comment Now Read Comment (1)

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App